DXCM — DexCom Inc · P/E 63, rev $2.50B

DexCom Inc (DXCM) is a medical devices company listed on US.

Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.

Use this DXCM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DXCM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DXCM SEC filings page. Lician reads the product cache first so this HTML stays unique to DexCom Inc even when a live quote feed is slow.

DexCom Inc latest statements (FY2025)

Latest cached year on this hub. Full DXCM income, balance, and cash tables.

  • Revenue$4.66B
  • Net Income$836.3M
  • Total Assets$6.34B
  • Total Debt$0
  • Free Cash Flow$1.08B

DXCM recent filings